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ABSTRACT

Polymerase chain reaction (PCR) is a technique that can amplify a specific DNA segment in vitro using
two site specific primers that hybridise to opposite DNA strands. The method produces large amounts of
specific DNA from a complex DNA template in a single enzymatic reaction within a matter of hours.
Reaction mixture contains a double helix DNA, two target specific primers, dNTPs, a DNA polymerase
and a Mg2+ containing buffer. PCR is carried out in three distinct steps i.e. denaturation step, annealing
step and extension step, which are repeated many times. The efficiency of PCR is measured in terms of
its specificity, yield and fidelity. Most of the disease pathologies are associated with an altered gene
expression leading to a resultant increase or decrease in the activity of cellular proteins. PCR can be
employed to quantify alterations in cellular mRNA encoding for such proteins. These proteins may serve
as novel target sites for therapeutic intervention. This modified form of PCR is termed as reverse
transcriptase PCR (RT-PCR). In situ PCR, another modified form of PCR, not only permits the quantification
of mRNA but also the exact localisation of mRNA changes in a particular cell type in a given tissue. PCR
has also been employed to amplify a family of related genes using degenerate oligo nucleotide primers
(DOP). This strategy is known as homology screening or DOP-PCR and has successfully expanded
several gene families such as cyclins and cyclin-dependent kinases. Besides these application of PCR
in pharmacology, it also serves as a useful diagnostic tool.
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Introduction
Recombinant DNA technology has emerged as a
powerful tool for in vivo DNA amplification in dividing
cells of micro-organisms. However, the technique is
labour intensive and time consuming. In 1984, Karry
Mullis while working with human-β-globin at Cetus
Corporation developed an in vitro method for DNA
amplification 1. This technique was termed as
polymerase chain reaction (PCR). PCR is an
enzymatic technique to amplify a specific DNA segment in vitro using two site specific primers that hybridise to complimentary DNA strands. The method
produces large amount of specific DNA from a complex DNA template in a single enzymatic reaction
within a matter of hours. Therefore, PCR is much
faster and simpler procedure as compared to
recombinant DNA technology. Moreover, PCR is a
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PCR

thermocycler

highly sensitive technique which can amplify even
picograms of DNA and starting DNA need not be
pure or free from contamination of cell components.
On the other hand, PCR amplifies DNA in a cell free
system and this has greatly simplified subsequent
cloning, analysis and modification of DNA. These advantages of PCR are reflected in an exponential increase in its use in the diverse scientific fields. The
present review intends to describe the basic methodology of PCR with its possible application to pharmacological sciences.
Principle and methodology
A typical PCR protocol is carried out in a reaction
mixture of 20-100 µl, either in individual tubes or
multiwell plates. Reaction mixture contains a double
helix DNA, two target specific primers, deoxynucleotide triphosphates (dNTPs), a DNA polymerase and
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a Mg2+ containing buffer. Mg2+ ions are required as a
cofactor for DNA polymerase. Primers are 17-30 base
containing oligonucleotides that hybridise to 5' end
of regions flanking the target DNA sequence. PCR
is carried out in three distinct cycles which are repeated many times. Each cycle begins with a denaturation step in which the reaction mixture is heated
to 92-96oC to denature the double stranded DNA.
Time required to denature DNA depends on its complexity, geometry of tubes and volume of reaction
mixture. For G≡C rich DNA sequence, addition of
glycerol, longer denaturation time and use of
nucleotide analogues has been reported to improve
yield of PCR3. Insufficient heating during denaturation step is the most common cause of PCR failure.
The denaturation step is followed by annealing step
in which the primers are allowed to hybridise to their
complementary DNA sequences. The temperature
of this step varies from 37oC to 65oC depending on
the homology of the primers for the target sequence
and the composition of the primers. Since the primers are present in high concentration and are short
in length, they hybridize to their target sequence at a
much higher rate than the complementary strands
of the target DNA. In the final step, the annealed
primer is extended at its 3' hydroxy position by a DNA
polymerase. This three step cycle is repeated many
times until a sufficient amount of target DNA is produced. Each extension product generated in one PCR
cycle can serve as a template for extension in the
next cycle (Figure 1). Therefore, PCR product increases exponentially as a function of the cycle
number. Earliest PCR experiments employed
klenow's fragment of E.coli DNA polymerase for DNA
extension step2. This enzyme has optimal activity at
37oC and often amplifies non-specific DNA target
products. Moreover, the enzyme gets inactivated at
higher temperature, therefore fresh enzyme has to
be added after each denaturation cycle. Later on, a
heat resistant DNA polymerase named as Taq
polymerase, was isolated from a thermophilic bacterium Thermus aquaticus3. Several thermostable DNA
polymerases have now been isolated from various
other thermophilic bacteria (Table 1). Unlike klenow
fragment, these enzymes escape inactivation during the denaturation cycle. Therefore, they need to
be added just once in the reaction mixture at the beginning. This has allowed automation of PCR using
programmable machines named as thermocyclers.

If the annealing step is carried out at low temperature, primers may hybridize to non-specific targets
due to looping out of primers at low temperature.
Thermostable polymerases allow annealing and extension at an elevated temperature, therefore amplify target DNA by minimising primer mismatch.
Moreover, these polymerases allow amplification of
much bigger DNA fragments as compared to 400bp
with klenow's fragments4.
The efficiency of PCR is measured in terms of its
specificity, yield and fidelity.
Optimization of PCR specificity
Specificity is achieved by designing primers of sufficient length so that their sequence is virtually unique
in the genome. Various additives such as DMSO1,5,6
(1-10%), glycerol5-7 (5-20%), non-ionic detergents,
formamide5,6,8 (1.25-10%), bovine serum albumin5-7
(10-100 µg/ml) and polyethyleneglycol 6000 (515%)9,10 can be incorporated into the reaction to increase PCR specificity. It has been proposed that
these reagents enhance specificity by lowering strand
separation temperature of DNA. At lower temperature, looping out of primers promotes formation of
primer template complexes that are not perfectly
matched and allow extension of mismatched target.
This can be avoided by hot start PCR11-13. Use of
klenow's fragment does not permit hot start and accounts for non-specific DNA amplification as was
mentioned above.
PCR specificity can also be enhanced by the use of
nested PCR. In this technique, products from first
PCR amplification are subsequently amplified using
a second set of primers which flank the same target
site but internal to original primers. Any spurious
product amplified in the first reaction by mispriming are
unlikely to possess the identical nucleotide sequence
for the internal primer. Therefore, only genuine product
will be amplified in the second reaction1,13-16.
Optimization of PCR yield
To maximize PCR yield, primers and dNTPs should
always be present in molar excess. However, if the
quantity of primers and dNTPs is excessively large,
PCR is prone to low specificity and fidelity respectively. The average yield of a PCR protocol can be
described by the following equation17:
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Table 1. Various thermostable DNA polymerases.
Enzyme

Source

Temperature (oC)

General applications

TaqTM

Thermus aquaticus

70-80

Stoffel

Thermus aquaticus

70-80

Thermus thermophilus

110-120

RT-PCR

Tli/Vent

Thermococcus litoralis

72-80

High fidelity PCR, LM PCR

pfuTM

Pyrococcus furiosus

72-80

High fidelity PCR, DNA sequencing

Bacillus stearothermophilus

60-65

High sensitivity

Sulfolobus acidocaldarius

70-80

DNA sequencing

Broad range

FragmentTM
TthTM
TM

Bst

TM

Sac
Tac

Thermoplasma acidophilum

65

AT rich DNA PCR

Tfl/TubTM

Thermus flavus

70

Large template DNA PCR

Tru

Thermus ruber

50

DNA sequencing

Tsp

Thermotoga sp

80

DNA sequencing

Mth

Methanobacterium
thermoautotrophicum

65

DNA sequencing

TM: Trademark

N=n(1+E)c

where N= final amount of target DNA
n=initial amount of DNA
E=efficiency of amplification
c=number of PCR cycles

However, the yield of PCR varies significantly depending upon the nature of the target sequence,
primer sequence and reaction conditions18,19.
Optimization of PCR fidelity
PCR infidelity, defined as rate of nucleotide
misincorporation, has been the subject of exhaustive investigation. Taq polymerase lacks 3'-5'
exonuclease proofreading activity and has a high
error rate in PCR. Nucleotide incorporation in PCRs
employing Taq polymerase is further dependent upon
dNTP concentration. Certain other thermostable
DNA polymerases such as Pfu or T4 polymerase
have 3'-5' proofreading activity and are reported to
improve fidelity 18,19. In general, rate of
misincorporation can be reduced by minimizing the
annealing or extention time, reducing dNTP and Mg2+

ion concentration and maximizing annealing temperature20. Unfortunately, the reaction conditions that minimize misincorporation also reduce PCR yield.
Analysis of PCR Product
(a) Electrophoresis
Agarose gel (typically 1-1.5% w/v) electrophoresis
followed by staining with ethidium bromide represents
the simplest and most common method to analyse
PCR product. PCR product is of a defined length.
The size of PCR product may be calculated by simultaneous running of DNA molecular weight marker
on the agarose gel. Excess primers may appear as
diffuse bands close to the leading edge of the gel21.
(b) Southern blotting and hybridisation
After electrophoresis, PCR amplified DNA template
is transferred (blotted) onto a nitrocellulose or nylon
membrane. Blotted DNA is denatured to single strand
and fixed onto the membrane by heating at 80oC or
by U.V. crosslinking. The membrane is then placed
in a solution contaning labelled (Radioactive or
flouresent) complementary single stranded
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Figure 1. Schematic representation of steps involved in PCR.

oligonucleotide known as probe. Hybridisation occurs between the lablled probe and complementary
single stranded sequence present on membrane. The
position of probe can be visualised by autoradiography or chemilumnisense22.
Modified versions of PCR
The basic technique of PCR has been modified in
several ways which has broadened its applications.
The detailed discussion of the modifications of PCR
techniques is beyond the scope of this review and
therefore, they are being mentioned only in brief.
Allele specific PCR is employed to detect point

mutations responsible for genetic disorders. Primers
are designed to anneal at the site which is probable
to undergo mutation. Therefore, primers will not anneal to this site if it has suffered from mutation and
DNA amplification will not take place in case of mutated genes23. Inverse PCR can be used to amplify
the unsequenced DNA template that lie adjacent to
a core DNA sequence for which the primer sequence
is already known24-26. Pan handle PCR allows the
amplification of DNA when the sequence for primer
design is known only on one end of target DNA sequence27,28. Race PCR is a technique to obtain full
length cDNA while starting from limited nucleotide
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sequence. PCR has also been employed to introduce point mutations in the target DNA. This technique termed as PCR mutagenesis, employs primers which are not exactly complementary to their target sequence but still undergo annealing under appropriate reaction conditions29-31. Ligation-mediated
PCR (LM PCR) is an extremely sensitive technique
to map single-stranded DNA breaks, DNA
methylation and nucleosome position. Therefore, the
technique is quite useful for toxicological studies32.
Arbitraily primed PCR (AP PCR) or DNA amplification finger printing is a technique which can be employed to identify genotypes or different strains of a
single species. The technique is of great importance
in diagnosis of microbial strains. In AP PCR, stringency of primer annealing is sufficiently lowered.
Therefore, primer binds to more than one target sites
in the DNA and amplifies more than one PCR
products. This set of PCR products is specific and
reproducible. After electrophoresis, it may be viewed
as finger print to identify source DNA33.
Applications of PCR in pharmacological research
1. Quantification of gene expression
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RT-PCR. From the ratio of amplified DNA, absolute
value of target cDNA can be calculated. Alternatively,
an endogenous gene transcript with high tissue expression can act as an internal standard. Such gene
transcripts are termed as "House keeping genes".
Genes for β-actin, HPRT and GAPDH are some of
the examples of house keeping genes routinely employed as internal standards34-37. However, the quantification relies on the empirical assumption that efficiency of PCR is same for target cDNA and standard DNA or endogenous gene. Therefore, this method
of mRNA quantification is less accurate.
Competitive RT-PCR
In contrast to non-competitive RT-PCR, this method
employs an external DNA standard that closely mimics target cDNA with respect to primer binding and
other PCR variables38-40. Therefore, standard and target cDNA get amplified with the same efficiency.
However, the method doesn't take into account the
efficiency of reverse transcription reaction. To overcome this limitation, samples have been spiked with
a known quantity of mRNA transcripts which are reverse transcribed and amplified in a manner analogous to target mRNA. This method is reported to yield
better results.

Discovery of a new target site for therapeutic intervention is every pharmacologist`s dream. Most of the
disease pathologies are associated with an altered
gene expression leading to an increase or decrease
in the activity of cellular proteins. PCR can be employed to detect very small alterations in cellular
mRNA encoding for such proteins. This modified form
of PCR is termed as reverse transcriptase PCR (RTPCR). In this technique, cellular RNA is initially reverse transcribed to cDNA in a reaction mixture containing oligo dT primers, a viral reverse transcriptase,
all four dNTPs and MgCl2 containing buffer. The cDNA
thus generated, can be amplified by PCR using primers specific to a particular mRNA. The final amount
of PCR product generated from mRNA, depends on
the starting amounts of mRNA and efficiency of the
reverse transcription and PCR reactions. In order to
rule out the variability due to later two factors, two
basic methods have been employed to quantitative
mRNA using RT-PCR.

RT-PCR has been employed to quantitate the mRNA
for many proteins. PGI2 synthase41, Cox 241, iNOS42,43,
AT1 receptors44, peroxisome proliferation activated
receptors45, matrix metalloprotinases (MMP-1, MMP3 and MMP-9)46, cGMP dependent protein kinase47,
cardiac background K+ channel48, human renin49,
NPY and NPY receptors50, endothelial leptin receptors51, human P2X7 receptor subtype52 mRNA are
just a few to name. Intrinsic expression of multidrug
resistance gene is a major impediment in the treatment of cancer by chemotherapy. The MDR phenotype may be caused by expression of transporters
of P glycoprotein family or multidrug resistance protein family53. Expression of MDR transporters serves
as an important predictor for clinical prognosis of
cancer54. RT-PCR has been extensively employed to
quantify the expression of MDR transporters in
several types of carcinomas53-57.

Noncompetitive RT-PCR

2. Cellular localisation of gene expression

In this method, a known quantity of standard DNA
template is added exogenously. Standard DNA and
target cDNA are co-amplified simultaneously using

Although RT-PCR is a highly sensitive technique to
detect small alteration in gene expression, it does
not permit the cellular localization of such gene
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alteration. Homogenized tissue samples employed
for RT-PCR mostly consist of heterogeneous group
of cells. Therefore, in a given pathological condition
it is difficult to ascribe the mRNA expression alteration to a particular cell type. In situ PCR overcomes
this short coming of RT-PCR. In this technique, a tissue section is fixed on a glass slide in formalin58.
Cellular proteins are digested on the slide with the
help of pepsin, trypsin or proteinase K. DNA is digested with help of DNAase. The total messenger
RNA is reversed transcribed to cDNA as described
in RT-PCR by putting all the reagents on slide. The
cDNA thus generated is amplified using two specific
set of primers, Taq polymerase and streptavidin containing dNTPs. Finally, this slide is stained with nuclear fast red stain and viewed under microscope.

4.

Gelfand DH, White TJ, Innis MA, Sninsky JJ. PCR
protocols: A guide to methods and amplifications. New York:
Academic Press; 1998.

5.

Cheng S, Fockler C, Barnes WH, Higuchi R. Effective amplification of long targets from cloned inserts and human
genomic DNA. Proc Natl Acad Sci 1994;91:5695-9.
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Vardaraj K, Skinner DH. Denaturation or cosolvents improve the specificity of PCR amplification of a G + C rich
DNA using genatically engeineered DNA polymerases.
Gene 1994;140:1-5.
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Cha RS, Zarbl H, Keohavong P, Thilly WG. Mismatch amplification mutation assay (MAMA): Application to the c-Hras gene. PCR Methods Appl 1992;2:14-20.

8.

Sarkar GS, Kapelner S, Sommer SS. Formamide can dramatically improve the specificity of PCR. Nucleic Acid Res
1990;18:74-85.

9.

Pomp D, Medrano JF. Organic solvents as facilitators of
polymerase chain reaction. Bioechniques 1991;16:812-4.

3. Identification of gene families
PCR has been employed to amplify a family of related genes using degenerate oligo nucleotide primers (DOP). DOP are mixture of primers designed
around a conserved domain of a gene family but with
alternative nucleotides at certain positions58. Therefore, these primers will bind to closely related DNA
sequences in the genome. This strategy is known as
homology screening or DOP-PCR and has successfully expanded several gene families such as cyclins
and cyclin-dependent kinases58.
PCR has also revolutionised the detection of genetic
disorders such as haemoglobinopathies, X-linked
disorders, cystic fibrosis, cancers such as acute
myeloid leukemia, chronic myeloid leukemia and infectious disorders such as tuberculosis, HIV and
hepatitis B. However, this use of PCR is more of a
diagnostic rather than pharmacological interest.
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